Friday, March 31, 2017

'We really have to take out the complexity that has been over-engineered into clinical trials' - Rob DiCicco, VP at GSK


We spoke to Rob DiCicco, Vice President of Clinical Innovation & Digital Platforms at GSK, on the hottest topics in clinical trials and how he sees them changing in the next year.

Speaking exclusively at Partnerships in Clinical Trials Europe 2016, DiCicco explores:
  • - Patient-centricity: 'We need an end-to-end strategy for patient engagement... If we ask to monitor them 24/7 over the course of a clinical trial and ask them to share all kinds of data, then we owe it to them to get them their trial results in a timely fashion.'
  • - Technology: 'The application of Big Data analytics ought to inform the development of clinical trial protocols... and help to drive decision making to streamline trials.'
  • - Challenges: 'We really have to take out the complexity that has been over-engineered into clinical trials.'
  • - Changes in 2017: 'I think you'll see technology companies try to evolve things that look like Electronic Health Record connectors.'
Watch the full interview above or here.

Technology and patient-centricity are key topics at T3: Trials, Tech and Transformation on May 11-12 in Orlando, Florida. Register today and use the exclusive code T3BLOG17 to save $200 on a two-day pass. Find out more here.




No comments: